This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Abl Bio Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Jin Won Jung - Innovator in Antibody-Drug Conjugates
Introduction
Jin Won Jung is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. His innovative work focuses on enhancing the stability and efficacy of these therapeutic agents.
Latest Patents
Jin Won Jung holds a patent for an "Antibody-drug conjugate having improved stability and use thereof." This invention relates to a conjugate that comprises a drug linked to an antibody, along with a preparation method and its applications. This advancement has the potential to improve treatment outcomes in various medical conditions.
Career Highlights
Jin Won Jung is currently associated with Abl Bio Inc., a company dedicated to developing innovative biopharmaceuticals. His work at Abl Bio Inc. emphasizes the importance of research and development in creating effective therapies for patients.
Collaborations
Some of his notable coworkers include Young Min Kim and Min Ji Ko, who contribute to the collaborative efforts in their research projects. Their teamwork enhances the innovative environment at Abl Bio Inc.
Conclusion
Jin Won Jung's contributions to the field of antibody-drug conjugates exemplify the impact of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for improving patient care through enhanced therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile